Search
Skip to Search Results- 2McMullen, Todd
- 1Bekele, Raie T.
- 1Benesch, Matthew
- 1Brindley, David N.
- 1Burrell, Robert
- 1Curtis, Jonathan M.
-
2019-12-10
McMullen, Todd, Burrell, Robert
NFRF Exploration awarded in 2020: Personalized therapy for patients with cancer remains one of the most important challenges facing clinicians and researchers. In this proposal we describe a point-of-care device that can diagnose disease, or provide prognostic information, by quantifying protein...
-
Oxidative stress mediates estrogen receptor independent killing and contributes to tamoxifen resistance
Download2016
Godbout, Roseline, Brindley, David N., McMullen, Todd, Mackey, John R., Benesch, Matthew, Mi, Si, Venkatraman, Ganesh, Liu, Rong-Zong, Curtis, Jonathan M., Tang, Xiaoyun, Bekele, Raie T.
Tamoxifen is the accepted therapy for patients with estrogen receptor-α (ERα)-positive breast cancer. However, clinical resistance to tamoxifen, as demonstrated by recurrence or progression on therapy, is frequent and precedes death from metastases. To improve breast cancer treatment it is vital...